Síguenos en Twitter       Síguenos en Facebook       Síguenos en YouTube       Siguenos en Linkedin       Correo Grupsagessa       Gmail       Yahoo Mail       Dropbox       Instagram       Pinterest       Slack       Google Drive       Print       StumbleUpon

SOBRE EL AUTOR **

Mi foto
FACP. Colegio de médicos de Tarragona Nº 4305520 / fgcapriles@gmail.com

WORLD EMERGENCY MEDICINE SOCIETIES & RELATED

Buscar en contenido

Contenido:

martes, 11 de junio de 2013

Manejo de anticoagulación: cirugía y procedimientos invasivos

 
(Review, NEJM) - PulmCCM June 07, 2013

"NOTE: This is a summary of an article in a medical journal, provided as a service to physicians. It is not medical advice. No one should never make changes to their anticoagulation treatment except under a physician’s supervision. Please read the Terms of Use before proceeding.
One in 50 people in the U.S. are taking long-term anticoagulation therapy for a condition like atrial fibrillation, a mechanical heart valve, or a clotting disorder resulting in DVT / PE. Millions more with coronary artery disease or strokes are taking antiplatelets drug like Plavix, and often aspirin as well. About 1 in 10 people on anticoagulation therapy undergo surgery or an invasive procedure each year, and the management of their anticoagulation medicines can be challenging: the physician is expected to simultaneously prevent serious bleeding during the surgery, and also clotting resulting in pulmonary embolism, heart attack, or embolic stroke. Tricky!"

También te podría interesar:
  1. Corrección de anticoagulación excesiva
  2. Dabigatran (Pradaxa®)
  3. Manejo de la anticoagulación
  4. Rivaroxaban (Xarelto)
  5. Trauma craneal en pacientes anticoagulados